BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 24510515)

  • 21. A Prime/Boost Vaccine Regimen Alters the Rectal Microbiome and Impacts Immune Responses and Viremia Control Post-Simian Immunodeficiency Virus Infection in Male and Female Rhesus Macaques.
    Musich T; Thovarai V; Venzon DJ; Mohanram V; Tuero I; Miller-Novak LK; Helmold Hait S; Rahman MA; Hunegnaw R; Huiting E; Yuan W; O'hUigin C; Hoang T; Sui Y; LaBranche C; Montefiori D; Bear J; Rosati M; Bissa M; Berzofsky JA; Pavlakis GN; Felber BK; Franchini G; Robert-Guroff M
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
    Abel K; Rourke T; Lu D; Bost K; McChesney MB; Miller CJ
    J Infect Dis; 2004 Nov; 190(9):1697-705. PubMed ID: 15478078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge.
    Kwa S; Lai L; Gangadhara S; Siddiqui M; Pillai VB; Labranche C; Yu T; Moss B; Montefiori DC; Robinson HL; Kozlowski PA; Amara RR
    J Virol; 2014 Sep; 88(17):9579-89. PubMed ID: 24920805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
    Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies.
    Van Rompay KK
    AIDS Res Hum Retroviruses; 2012 Jan; 28(1):16-35. PubMed ID: 21902451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA vaccination for HIV-1 and SIV.
    Barouch DH; Letvin NL
    Intervirology; 2000; 43(4-6):282-7. PubMed ID: 11251383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene-based vaccination with a mismatched envelope protects against simian immunodeficiency virus infection in nonhuman primates.
    Flatz L; Cheng C; Wang L; Foulds KE; Ko SY; Kong WP; Roychoudhuri R; Shi W; Bao S; Todd JP; Asmal M; Shen L; Donaldson M; Schmidt SD; Gall JG; Pinschewer DD; Letvin NL; Rao S; Mascola JR; Roederer M; Nabel GJ
    J Virol; 2012 Aug; 86(15):7760-70. PubMed ID: 22593152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine-based, long-term, stable control of simian/human immunodeficiency virus 89.6PD replication in rhesus macaques.
    Yamamoto H; Kawada M; Tsukamoto T; Takeda A; Igarashi H; Miyazawa M; Naruse T; Yasunami M; Kimura A; Matano T
    J Gen Virol; 2007 Feb; 88(Pt 2):652-659. PubMed ID: 17251584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tackling HIV and AIDS: contributions by non-human primate models.
    Van Rompay KKA
    Lab Anim (NY); 2017 May; 46(6):259-270. PubMed ID: 28530684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus Monkeys.
    Pan E; Feng F; Li P; Yang Q; Ma X; Wu C; Zhao J; Yan H; Chen R; Chen L; Sun C
    Front Immunol; 2018; 9():2415. PubMed ID: 30405615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of primate models for AIDS.
    Haigwood NL
    AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical AIDS vaccine development: formal survey of global HIV, SIV, and SHIV in vivo challenge studies in vaccinated nonhuman primates.
    Warren JT; Levinson MA
    J Med Primatol; 1997; 26(1-2):63-81. PubMed ID: 9271191
    [No Abstract]   [Full Text] [Related]  

  • 33. Genomic analysis reveals pre- and postchallenge differences in a rhesus macaque AIDS vaccine trial: insights into mechanisms of vaccine efficacy.
    Palermo RE; Patterson LJ; Aicher LD; Korth MJ; Robert-Guroff M; Katze MG
    J Virol; 2011 Jan; 85(2):1099-116. PubMed ID: 21068249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates.
    Bertley FM; Kozlowski PA; Wang SW; Chappelle J; Patel J; Sonuyi O; Mazzara G; Montefiori D; Carville A; Mansfield KG; Aldovini A
    J Immunol; 2004 Mar; 172(6):3745-57. PubMed ID: 15004179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses.
    Abel K; Pahar B; Van Rompay KK; Fritts L; Sin C; Schmidt K; Colón R; McChesney M; Marthas ML
    J Virol; 2006 Jul; 80(13):6357-67. PubMed ID: 16775324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.
    Iyer SS; Gangadhara S; Victor B; Shen X; Chen X; Nabi R; Kasturi SP; Sabula MJ; Labranche CC; Reddy PB; Tomaras GD; Montefiori DC; Moss B; Spearman P; Pulendran B; Kozlowski PA; Amara RR
    J Virol; 2016 Oct; 90(19):8842-54. PubMed ID: 27466414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
    Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
    J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents.
    Gardner MB
    Antiviral Res; 1991 May; 15(4):267-86. PubMed ID: 1659310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunodeficiency lentiviral infections in natural and non-natural hosts.
    Brenchley JM; Paiardini M
    Blood; 2011 Jul; 118(4):847-54. PubMed ID: 21505193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection.
    Mooij P; Nieuwenhuis IG; Knoop CJ; Doms RW; Bogers WM; Ten Haaft PJ; Niphuis H; Koornstra W; Bieler K; Köstler J; Morein B; Cafaro A; Ensoli B; Wagner R; Heeney JL
    J Virol; 2004 Apr; 78(7):3333-42. PubMed ID: 15016855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.